Experiment 491295

Worktypes

EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

VIRIDOGRISEIN

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTITREPONEMAL ACTIVITY
OrganismStreptomyces cacaoi (STREPTOMYCETACEAE)
CitationASANO,T: HARA,T: TAKAGI,H: KEYAKIDA,K:. (1992). GRISEOVIRIDIN FOR PREVENTION AND TREATMENT OF SWINE DYSENTERY.. 1992()
Amount utilized
Compound isolated
DiseaseA 1:1 MIXTURE OF GRISEOVIRIDIN AND VIRIDOGRISEIN WAS USED. COMPOUND METABOLIZED TO 5 MONOMERS: ANHYDROALKANNIN, DEOXYSHIKONIN, CYCLOSHIKONIN, METABOSHIKONIN AND AN UNNAMED COMPOUND, AND TO 5 DIMERS: SHIKOMETABOLINS A, B, C, D, E.
Dose amount0.39 MCG
Number6
Qualitative resultACTIVE
AnimalAGAR PLATE
Per unitML
Dose expressionMIC